These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12057106)

  • 1. Determining the optimal treatment for advanced bladder cancer.
    Freedland SJ; Chao D; Pantuck AJ; Zisman A; Belldegrun AS
    Rev Urol; 2001; 3(3):159-62. PubMed ID: 16985712
    [No Abstract]   [Full Text] [Related]  

  • 2. Tibial metastasis from muscle invasive bladder carcinoma: an unusual site.
    Brennan D; Kelly ME; Nason GJ; Collins-Smyth C; McGuire BB; Lennon GM
    Curr Urol; 2013 Feb; 7(3):160-2. PubMed ID: 24917780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Denosumab: a new option in the treatment of bone metastases from urological cancers.
    Yuasa T; Yamamoto S; Urakami S; Fukui I; Yonese J
    Onco Targets Ther; 2012; 5():221-9. PubMed ID: 23055747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells.
    Chadalapaka G; Jutooru I; Safe S
    Carcinogenesis; 2012 Apr; 33(4):886-94. PubMed ID: 22334592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solitary skin metastasis from sarcomatoid carcinoma of the bladder: a case report.
    Manzelli A; Quaresima S; Rossi P; Petrou A; Ricciardi E; Brennan N; Kontos M; Petrella G
    J Med Case Rep; 2011 Sep; 5():484. PubMed ID: 21955819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urothelial bladder cancer with cavitary lung metastases.
    Kurian A; Lee J; Born A
    Can Respir J; 2011; 18(3):e46-7. PubMed ID: 21766082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of biweekly plitidepsin as second-line therapy for advanced or metastatic transitional cell carcinoma of the urothelium.
    Dumez H; Gallardo E; Culine S; Galceran JC; Schöffski P; Droz JP; Extremera S; Szyldergemajn S; Fléchon A
    Mar Drugs; 2009 Sep; 7(3):451-63. PubMed ID: 19841725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo.
    Sato K; Yuasa T; Nogawa M; Kimura S; Segawa H; Yokota A; Maekawa T
    Br J Cancer; 2006 Nov; 95(10):1354-61. PubMed ID: 17043684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
    deVere White RW; Katz MH; Steinberg GD
    J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
    [No Abstract]   [Full Text] [Related]  

  • 10. Locally advanced and metastatic bladder cancer.
    Dreicer R
    Curr Treat Options Oncol; 2001 Oct; 2(5):431-6. PubMed ID: 12057106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
    Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W
    J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.
    Splinter TA; Scher HI; Denis L; Bukowski R; Soloway M; Vogelzang N; Klimberg I; Dalesio O; Herr H
    Prog Clin Biol Res; 1990; 353():219-24. PubMed ID: 2217422
    [No Abstract]   [Full Text] [Related]  

  • 14. [The prognostic value of adjuvant and neoadjuvant chemotherapy in total cystectomy for locally advanced bladder cancer].
    Habuchi T; Kakehi Y; Terachi T; Ogawa O; Yoshida O
    Nihon Hinyokika Gakkai Zasshi; 1999 Oct; 90(10):809-17. PubMed ID: 10565159
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.